Act Capital Management, LLC Tg Therapeutics, Inc. Transaction History

Act Capital Management, LLC

  • $72.5 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 11, 2022
SELL
$7.81 - $20.45 $264,759 - $693,255
-33,900 Closed
0 $0
Q4 2021

Feb 03, 2022
SELL
$15.2 - $35.51 $396,720 - $926,811
-26,100 Reduced 43.5%
33,900 $644,000
Q3 2021

Nov 16, 2021
BUY
$21.78 - $40.45 $108,900 - $202,250
5,000 Added 9.09%
60,000 $2 Million
Q2 2021

Aug 16, 2021
BUY
$32.5 - $48.96 $1.79 Million - $2.69 Million
55,000 New
55,000 $2.13 Million

Others Institutions Holding TGTX

# of Institutions
338
Shares Held
87.7M
Call Options Held
2.35M
Put Options Held
1.7M
View Full List

About TG THERAPEUTICS, INC.

TGTX Quotes by TradingView
  • Ticker TGTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 145,274,000
  • Market Cap $4.67B
  • Description
  • TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...
More about TGTX
Track This Portfolio

Track Act Capital Management, LLC Portfolio

Follow Act Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Act Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Act Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email